Department of Anaesthesia and Intensive Care, Hospital Universitario Ramon y Cajal, IRYCIS, Madrid, Spain.
Department of Health Science, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
Anaesthesiol Intensive Ther. 2022;54(4):295-301. doi: 10.5114/ait.2022.121091.
COVID-19 is associated with severe respiratory distress and high mortality. We investigated the evolution of the respiratory mechanics in COVID-19 acute respiratory distress syndrome (ARDS) and the occurrence of a restrictive respiratory pattern.
A retrospective, single-centre study including patients admitted to the ICU during the first wave of the pandemic (March-April 2020).
A total of 141 consecutive patients were included. Many patients developed a restrictive pattern of respiratory mechanics during the course of the disease. Fifty-two patients died in the hospital (36.8%). In 29 cases (58% of the deceased) death was associated with a pattern of pulmonary mechanics, indicating a restrictive evolution of ARDS. Other diagnoses related to death were pulmonary embolism (n = 7, 14%), septic shock (n = 17, 33%), and other causes (n = 10, 20%), with some patients combining at least 2 of these diagnoses. In a multivariate analysis, age (OR = 1.06; 95% CI: 1.01-1.12; P = 0.029) and the administration of steroid pulses (OR = 2.7; 95% CI: 1.1-6.8; P = 0.03) were associated with the development of a restrictive pulmonary pattern and a higher level of plasmatic interleukin-6.
COVID-19 ARDS is associated with high mortality associated with a specific pattern of respiratory mechanics and sustained activation of innate immunological response. Age and administration of high-dose steroid pulses are associated with this clinical picture.
COVID-19 与严重的呼吸窘迫和高死亡率有关。我们研究了 COVID-19 急性呼吸窘迫综合征(ARDS)患者的呼吸力学演变情况,以及是否出现限制性呼吸模式。
这是一项回顾性、单中心研究,纳入了在大流行第一波期间(2020 年 3 月至 4 月)入住 ICU 的患者。
共纳入 141 例连续患者。许多患者在疾病过程中出现了限制性呼吸力学模式。52 例患者在医院死亡(36.8%)。在 29 例死亡病例(死亡患者的 58%)中,死亡与肺力学模式相关,表明 ARDS 的限制性演变。与死亡相关的其他诊断包括肺栓塞(n=7,14%)、感染性休克(n=17,33%)和其他原因(n=10,20%),有些患者至少合并了其中 2 种诊断。多变量分析显示,年龄(OR=1.06;95%CI:1.01-1.12;P=0.029)和皮质类固醇冲击治疗(OR=2.7;95%CI:1.1-6.8;P=0.03)与限制性肺模式的发展和血浆白细胞介素-6 水平升高相关。
COVID-19 ARDS 与死亡率高相关,其与特定的呼吸力学模式和固有免疫反应的持续激活有关。年龄和大剂量皮质类固醇冲击治疗与这种临床表现有关。